UK

Batch testing pharmaceuticals
#ABPI #Batch testing #EU #Pharmaceuticals #Testing #UK

UK clarifies post-BREXIT batch testing rules for pharmaceuticals 

The UK government has announced its future strategy for batch testing of medicinal products.  The new strategy means that the UK will continue to recognise batch testing from the EU/EEA, rather than insisting on duplicative batch testing operations.  Post-BREXIT, the pharmaceutical industry urged the UK… Read More

#News

Cambridge University
#AstraZeneca #Cambridge Innovation Park #Innovation #UK

AstraZeneca joins Cambridge scientific innovation committee

An initial 100 organisations have signed an agreement to support, promote and enhance innovation in the Greater Cambridge area.  Signatories to the ‘Innovate Cambridge Charter’ also hope to develop a set of ecosystem-wide initiatives that ensure Cambridge continues to compete effectively on the international stage in the… Read More

#News

Hemp plants being used in scientific research
#Chronic pain #MHRA #THC #UK

UK approval for CBD pain treatment

The UK Medicines and Healthcare Products Regulatory Agency (MHRA) has approved a CBD/THC combination treatment under its Named Patient programme and other compassionate areas. Medlab’s NanaBis, to be used under NanaDol, a botanical version of NanaBis, has previously shown encouraging Phase I/II data for the treatment of cancer-induced bone pain… Read More

#News #Regulatory #Trending News

Child having physiotherapy
#Gene therapy #MHRA #Rare disease #UK

Gene therapy could ‘transform prognosis’ for AADC deficiency patients 

PTC Therapeutics’ Upstaza (eladocagene exuparvovec) has received authorisation from the Medicines and Healthcare Products Regulatory Agency (MHRA) in the UK.   Upstaza is the first approved disease-modifying treatment for aromatic L-amino acid decarboxylase (AADC) deficiency. It is also the first marketed gene therapy directly infused into the brain. The MHRA marketing… Read More

#News #Regulatory

World AMR Awareness Week logo
#ABPI #Antibiotic resistance #Antibiotics #Antimicrobial resistance (AMR) #Association of the British Pharmaceutical Industry #UK

New antibiotics the only way to combat AMR, says ABPI 

Developing new antibiotics is essential to winning the fight against resistant infections, the Association of the British Pharmaceutical Industry (ABPI) has said.  The comments come ahead of World Antimicrobial Awareness Week (18-24 November), which aims to improve the awareness and understanding of antimicrobial resistance (AMR).   The… Read More

#News #Trending News

UK on global map
#BioIndustry Association #Biologics / Biotechnology #Equity finance #Finance #Fundraising #Investment #Life sciences #Market reporting #Private investment #Seed funding #UK

UK remains strongest biotech hub in Europe despite general decline

After a disappointing start to the year, the last few months have seen a boost to fundraising for UK biotech companies. DDW’s Diana Spencer unpacks the Q3 figures and annual predictions from the BioIndustry Association1.  While 2021 was the highest year on record for investments into UK biotech and life… Read More

#Business & Investment #Exclusive Content #Market Reports

Our Future Health study
#Genetic study #Health research programme #NHS #Our Future Health #Predictive diagnostics #UK

Millions invited to join UK’s largest health research programme

Over three million people have been invited to join Our Future Health, which is set to become the UK’s largest ever health research programme. Letters are being sent out this autumn inviting members of the public to join Our Future Health, designed to help develop new ways to prevent, detect… Read More

#News #Trending News

Contraceptive pill
#Contraception #Contraceptive pill #Gedeon Richter #Synthetic oestrogen #UK

First synthetic contraceptive pill launched in UK

The first and only oral contraception containing a new, synthetic version of a naturally occurring oestrogen has been launched in the UK.  Gedeon Richter’s Drovelis (14.2mg estetrol [E4] plus 3mg drospirenone [DRSP]) as a combined oral contraceptive is now available.  The company cautions that any… Read More

#News